- Home
- SMTI vs MVT Comparison
SMTI vs MVT Comparison
Compare SMTI & MVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- MVT
- Stock Information
- Founded
- SMTI 1982
- MVT 1993
- Country
- SMTI United States
- MVT United States
- Employees
- SMTI N/A
- MVT N/A
- Industry
- SMTI Medical/Dental Instruments
- MVT Investment Bankers/Brokers/Service
- Sector
- SMTI Health Care
- MVT Finance
- Exchange
- SMTI Nasdaq
- MVT Nasdaq
- Market Cap
- SMTI 288.2M
- MVT 238.0M
- IPO Year
- SMTI N/A
- MVT N/A
- Fundamental
- Price
- SMTI $34.39
- MVT $11.08
- Analyst Decision
- SMTI Buy
- MVT
- Analyst Count
- SMTI 1
- MVT 0
- Target Price
- SMTI $44.00
- MVT N/A
- AVG Volume (30 Days)
- SMTI 24.7K
- MVT 49.7K
- Earning Date
- SMTI 11-12-2024
- MVT 01-01-0001
- Dividend Yield
- SMTI N/A
- MVT 4.15%
- EPS Growth
- SMTI N/A
- MVT N/A
- EPS
- SMTI N/A
- MVT N/A
- Revenue
- SMTI $72,410,222.00
- MVT N/A
- Revenue This Year
- SMTI $26.97
- MVT N/A
- Revenue Next Year
- SMTI $18.91
- MVT N/A
- P/E Ratio
- SMTI N/A
- MVT N/A
- Revenue Growth
- SMTI 21.42
- MVT N/A
- 52 Week Low
- SMTI $26.00
- MVT $8.96
- 52 Week High
- SMTI $43.25
- MVT $11.17
- Technical
- Relative Strength Index (RSI)
- SMTI 64.02
- MVT 51.76
- Support Level
- SMTI $32.91
- MVT $10.85
- Resistance Level
- SMTI $34.03
- MVT $11.08
- Average True Range (ATR)
- SMTI 1.39
- MVT 0.14
- MACD
- SMTI 0.24
- MVT 0.02
- Stochastic Oscillator
- SMTI 100.00
- MVT 70.13
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About MVT Blackrock MuniVest Fund II Inc.
Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.